Tenaya Therapeutics (TNYA) Other Gross PP&E Adjustments (2020 - 2026)

Tenaya Therapeutics has reported Other Gross PP&E Adjustments for 7 years, with the latest figure at $58.8 million in Q1 2026.

• For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 3.96% year-over-year to $58.8 million; the trailing twelve-month figure through Mar 2026 stood at $58.8 million (up 3.96% YoY), and the FY2025 full-year result was $57.5 million, up 2.94% from the prior year.
• Other Gross PP&E Adjustments for Q1 2026 stood at $58.8 million, up from $57.5 million in the prior quarter.
• The five-year high for Other Gross PP&E Adjustments was $58.8 million in Q1 2026, with the low at $47.9 million in Q1 2022.
• Average Other Gross PP&E Adjustments over 5 years is $55.5 million, with a median of $56.4 million recorded in 2023.
• Year-over-year, Other Gross PP&E Adjustments jumped 153.63% in 2022 and dropped 4.4% in 2024.
• Tracing TNYA's Other Gross PP&E Adjustments over 5 years: stood at $54.6 million in 2022, then increased by 4.27% to $56.9 million in 2023, then retreated by 1.88% to $55.8 million in 2024, then advanced by 2.94% to $57.5 million in 2025, then climbed by 2.37% to $58.8 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at $58.8 million (Q1 2026), $57.5 million (Q4 2025), and $57.9 million (Q3 2025), per Business Quant data.

Peer Comparison